Sitaglu Met XR 50/500mg Tablets 28s – Extended-Release Dual Therapy
Sitaglu Met XR 50/500mg Tablets 28s – Extended-Release Dual Therapy
Description
Sitaglu Met XR 50/500mg Tablets – Gentle Once-Daily Combination for Blood Sugar Stability
Sitaglu Met XR 50/500mg Tablets combine sitagliptin 50mg and extended-release metformin hydrochloride 500mg to offer balanced, long-acting control for adults with type 2 diabetes. Sitagliptin works as a DPP-4 inhibitor to enhance incretin hormones, promoting insulin release only when blood sugar is elevated and reducing glucagon levels, while the extended-release metformin gradually improves insulin sensitivity and lowers liver glucose production throughout the day. This dual-action formula provides effective HbA1c reduction and steady management of fasting and post-meal glucose levels.
The extended-release technology minimizes common gastrointestinal side effects, making it a well-tolerated option for patients starting combination therapy or those seeking simpler once-daily dosing alongside diet and exercise under medical guidance.
